Santa Cruz Biotechnology

PADI2 (4D4) | Santa Cruz Biotechnology

mouse monoclonal IgG1; PADI2 Antibody (4D4) is an IgG1 κ mouse monoclonal PADI2 antibody (also designated PADI2 antibody) that detects the PADI2 protein of mouse, rat and human origin by WB, IP and ELISA. PADI2 Antibody (4D4) is available as the non-conjugated anti-PADI2 antibody. The protein arginine deiminase (PAD) family of proteins, often referred to as peptidylarginine deiminases, catalyze the deimination of arginine residues of proteins. In the presence of calcium, the proteins in the PAD family act as catalysts for the posttranslational modification reaction that converts methylarginine to citrulline. The PAD proteins are cytoplasmic proteins primarily detected in eosinophils and neutrophils. The only tissue that contains all four forms of PAD (PADI1-4) is epidermis. PADI2 may play a crucial role during terminal differentiation of epidermal keratinocytes.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.